Clinical Trial Update: Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching from entecavir to Vemliver in adults with chronic hepatitis B; results assess efficacy and safety after switching.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Vemliver

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED